Modified-peptide inhibitors of amyloid beta-peptide polymerization.

@article{Findeis1999ModifiedpeptideIO,
  title={Modified-peptide inhibitors of amyloid beta-peptide polymerization.},
  author={Mark A. Findeis and Giovanni Musso and Christopher Arico-Muendel and H W Benjamin and A M Hundal and Jung Joon Lee and Jean Chin and Michael Kelley and Jim Wakefield and N J Hayward and Susan M. Molineaux},
  journal={Biochemistry},
  year={1999},
  volume={38 21},
  pages={6791-800}
}
Cellular toxicity resulting from nucleation-dependent polymerization of amyloid beta-peptide (Abeta) is considered to be a major and possibly the primary component of Alzheimer's disease (AD). Inhibition of Abeta polymerization has thus been identified as a target for the development of therapeutic agents for the treatment of AD. The intrinsic affinity of Abeta for itself suggested that Abeta-specific interactions could be adapted to the development of compounds that would bind to Abeta and… CONTINUE READING
50 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

Similar Papers

Loading similar papers…